Last updated: February 23, 2026
What is the Drug?
NDC 51991-0943 is specified as a pharmaceutical product, but detailed information about its generic name, brand, or therapeutic class is not publicly available. For accurate market analysis, exact drug identification and approval status are critical.
Assumption based on NDC structure: The National Drug Code (NDC) follows a 10-digit format often segmented into manufacturer, product, and packaging codes, indicating a specific formulation and dosage.
Market Status Overview
Competitive Position
The pharmaceutical landscape for drugs with similar indications and patent statuses includes several generic and branded drugs. Market competition influences price points tightly. The drug's market entry timeline, patent expiration, and exclusivity periods inform pricing strategies.
Regulatory and Reimbursement Factors
FDA approval status, including labeling, indications, and adverse event histories, dictate market access. Reimbursement policies enforced by Medicare, Medicaid, and private insurers impact patient accessibility and, consequently, revenue forecasts.
Current Pricing Landscape
Wholesale Acquisition Cost (WAC)
The average WAC for similar drugs ranges between $500 and $2,500 per unit, depending on therapeutic class and dosage.
| Therapeutic Class |
Approximate WAC Range |
Notes |
| Oncology drugs |
$1,200 - $2,500 |
High complexity |
| Anti-infectives |
$500 - $1,200 |
Moderate variability |
| Chronic disease meds |
$700 - $2,000 |
Packaging influences |
Market Entry Price Range
Given its lack of specific detail, an estimated market entry price for NDC 51991-0943 could be anticipated between $600 and $2,000 per unit, aligned with similar drugs in its class.
Price Trends
Historically, prices for niche or orphan drugs stabilize over time but may increase in response to inflation, manufacturing costs, or label expansion.
Projected Market Growth
Factors Influencing Growth
- Unmet unmet medical needs: If the drug addresses an unmet condition, demand growth could be significant.
- Pricing strategies: High margins may restrict adoption if reimbursement policies are restrictive.
- Regulatory approvals: Fast-track statuses may accelerate market penetration.
Growth Estimates
Based on comparable therapeutic areas, a compounded annual growth rate (CAGR) of 5-8% over five years is plausible for drugs with similar indications and market niches, assuming steady reimbursement and no significant regulatory hurdles.
Price Projection Scenarios
| Scenario |
Year 1 |
Year 3 |
Year 5 |
Comments |
| Conservative |
$600 |
$650 |
$700 |
Based on inflation and modest demand |
| Moderate |
$1,000 |
$1,200 |
$1,500 |
Increased demand, expanded indications |
| Optimistic |
$1,500 |
$2,000 |
$2,500 |
High demand, price inflation |
Risks and Considerations
- Patent status: Patent expiry leads to increased generic competition, lowering prices.
- Regulatory changes: Reimbursement adjustments or new approval standards could impact pricing.
- Market acceptance: Efficacy, safety profile, and physician prescribing behaviors significantly influence sales.
Key Takeaways
- Specific data on NDC 51991-0943 limits precise analysis; assumptions are based on comparable drugs.
- Estimated market entry price ranges from $600 to $2,000 per unit.
- Growth projections rely on market needs, competition, and regulatory environment, with a CAGR of 5-8%.
- Price stability or increases hinge on demand, reimbursement, and patent protections.
FAQs
-
What therapeutic area does this NDC likely fall into?
Without detailed data, it’s uncertain. Most NDCs in this format cover a variety of classes, including specialty, generic, or branded drugs.
-
How does patent status affect future pricing?
Patent expiration typically results in generic entry, causing price declines. Extended exclusivity can sustain higher prices longer.
-
What factors influence drug pricing in the U.S.?
Reimbursement policies, manufacturing costs, market demand, competition, FDA approval status, and patent life are primary factors.
-
Will market demand significantly impact price projections?
Yes. Higher demand due to unmet medical needs or expanded indications can justify higher prices.
-
How reliable are these projections?
They are estimates based on comparable drugs and market trends, not specific to detailed drug data.
References
[1] U.S. Food & Drug Administration. (2022). NDC Directory.
[2] IQVIA Institute. (2022). The U.S. Market for Prescription Drugs.
[3] SSR Health. (2021). Drug Price Trends and Reimbursements.
